The Effect of Guilingji Capsules on Vascular Mild Cognitive Impairment: A Randomized, Double-Blind, Controlled Trial
Table 1
Baseline characteristics of the patients.
GLJC group (n = 37)
Ginkgo group (n = 45)
value
Age, years, mean (SD)
69.54 (7.10)
70.58 (7.22)
0.516
Sex, n (%)
0.204
Male
20 (54.95)
18 (40.00)
Female
17 (45.95)
27 (60.00)
Education level, n (%)
0.869
Below primary school
0 (0)
0 (0)
Primary school
6 (16.22)
6 (13.33)
Middle school
16 (43.24)
18 (40.00)
High school or above
15 (40.54)
21(46.67)
BMI, kg/m2, median (IQR)
23.42 (22.20–24.97)
23.53 (21.81–25.32)
0.783
Risk factors, n (%)
0.616
Hypertension
16 (43.24)
15 (33.33)
Diabetes
12 (32.43)
9 (20.00)
Hyperlipidemia
4 (10.81)
8 (17.78)
Coronary artery disease
11 (29.73)
11 (24.44)
Abnormally craniocerebral CT, n (%)
0.370
Cerebral infarction
21 (56.76)
31 (68.89)
Cerebral ischemia
9 (24.32)
7 (15.56)
Leukodystrophy
10 (27.03)
8 (17.78)
Note: sex, education level, hypertension, diabetes, hyperlipidemia, coronary heart disease history, and abnormal craniocerebral CT scans were analyzed using the chi-square test (χ2 test). BMI: body mass index; CT: computed tomography.
